Nutanix (NTNX) closed the most recent trading day at $70.85, moving -1.03% from the previous trading session. This move lagged the S&P 500's daily gain of 0.36%. On the other hand, the Dow registered ...

Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2025, which ended January 31, ...

Nutanix study reveals that GenAI is changing organizations priorities, with security and privacy being a primary concern ...

In a regulatory filing, Nutanix (NTNX) disclosed that its CEO Rajiv Ramaswami sold 95.9K shares of common stock on February 4th in a total ...

Rajiv Ramaswami, the President and CEO of Nutanix, Inc. (NASDAQ:NTNX), has sold 95,852 shares of the company's Class A common ...

The company said the vulnerability was discovered in the Veeam Updater component, allowing threat actors to run ...

Federal employees had been told they'd have until today to decide whether to opt in to the program, which is now under a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

As the Trump administration considers options for workforce reductions, experts warn RIFs can open agencies to legal challenges and worsening productivity.

It’s no secret that cloud adoption continues to grow in healthcare, evolving from a nice-to-have feature to an essential part ...

VMware customers see Broadcom’s actions as an opportunity to rethink virtualization, cloud strategy and modernization efforts ...

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine ...